At Yecuris, we believe

• Preclinical research should be as predictive as possible, allowing drug
developers to gain critical insights, proceed into the clinic with certainty, and
have the confidence to make tough go/no go decisions

• The unique ability to use the same donor cells in vivo and in vitro bridge the preclinical pathway to the clinic, giving our clients the greatest predictive data possible

• Our singular goal is to deliver actionable results our clients can depend on,
bringing human relevance to the earliest stages of the drug development
process.